JUDITH RAO: Open Payments
NPI 1457128951 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $599 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| GENZYME CORPORATION | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Ardelyx, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: DUPIXENT, XIFAXAN, REZDIFFRA, VOQUEZNA, OMVOH, IBSRELA, ENTYVIO.
Industry payments across TX — which companies pay providers there.
